Quantitative analysis for Cronos Group Inc. (CRON) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (60.0) (grade B). 26 signals analyzed (22 differentiated alt-data).
CRON stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $2.62 | $2.55 | $2.58 |
| 2026-05-11 | $2.94 | $2.65 | $2.75 |
| 2026-05-21 | $2.75 | $2.66 | $2.73 |
| 2026-06-03 | $2.74 | $2.65 | $2.71 |
| 2026-06-15 | $2.72 | $2.61 | $2.63 |
| 2026-06-26 | $2.83 | $2.72 | $2.81 |
| 2026-07-09 | $2.79 | $2.72 | $2.78 |
| 2026-07-21 | $2.82 | $2.78 | $2.80 |
| 2026-07-31 | $2.90 | $2.81 | $2.83 |
| 2026-08-12 | $3.17 | $3.04 | $3.17 |
| 2026-08-24 | $3.45 | $3.27 | $3.41 |
| 2026-09-03 | $3.29 | $3.21 | $3.26 |
How Cronos Group Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| DRTS | Alpha Tau Medical Ltd. | $984M | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | $982M | — |
| BTX | BlackRock Technology and Private Equity Term Trust | $1.0B | — |
| ALVO | Alvotech | $1.0B | — |
View all Health Care stocks by valuation and signals →
Cronos Group Inc. (CRON) scores Buy (60.0) across 3 measured dimensions, ranging from technicals at 64 down to analyst consensus at 25. The spread of 39 points is narrow enough that no single dimension dominates the composite. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 64 |
| competitive moat | 42 |
| analyst consensus | 25 |
StoQuant analyzes 26 signals (22 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Cronos Group Inc. (CRON): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/CRON"><img src="https://stoquant.com/badge/CRON.svg" alt="Cronos Group Inc. (CRON) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.